BOSTON--(BUSINESS WIRE)--AI Proteins, Inc., a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins, is thrilled to announce that it has been selected as one of the 25 winners of the prestigious Falling Walls Venture Science Start-up competition. The company’s cutting-edge technology has earned a spot among the world’s most promising startups.
The Falling Walls Venture competition is a global platform that recognizes and supports groundbreaking scientific breakthroughs. This recognition validates AI Proteins’ commitment to engineering and developing protein-based medicines with ideal therapeutic characteristics, leveraging a novel approach for designing entirely new proteins. As a winner, AI Proteins will present and pitch its innovative solutions to a global audience of investors, industry leaders, and policymakers at the Falling Walls Conference in Berlin, Germany, on November 7-9, 2024.
“We are honored to be selected as a Falling Walls Venture winner,” said Dr. Chris Bahl, founder, President, and Chief Scientific Officer of AI Proteins. “This recognition is a testament to the hard work and dedication of our team. We are excited to showcase our technology on the world stage and continue to drive innovation in protein-based therapeutics.”
About AI Proteins
Boston-based AI Proteins is a biotech company on a mission to re-imagine protein therapeutics with a novel approach for designing entirely new proteins. Using AI-based design and a high-throughput drug discovery platform, AI Proteins creates de novo miniproteins optimized for a variety of therapeutic applications, and the company is currently advancing its own pipeline in oncology while exploring partnerships in inflammation, metabolic diseases and other therapeutic areas. The company’s technology enables the development of inexpensive, durable, highly specific proteins with unique therapeutic properties and with the potential for multiple routes of delivery. Additionally, the AI Proteins platform can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. For more information, please visit aiproteins.com.
About the Falling Walls Science Summit
Since its inception in 2009, Falling Walls Science Summit (formerly the Falling Walls Conference) has become a leading international, interdisciplinary and intersectoral forum for scientific breakthroughs and dialogue between science and society. The event takes place every year from 7-10 November in Berlin, commemorating the fall of the Berlin Wall. With formats Falling Walls Pitches (7 November), Falling Walls Circle (8 November) and Falling Walls Science Breakthroughs of the Year (9 November), the Falling Walls Science Summit brings together global leaders from academia, business, politics, media, and civil society to debate the potential of scientific breakthroughs to solve grand challenges and shape a sustainable future. The Falling Walls Science Summit is organized by the non-profit Falling Walls Foundation. More: falling-walls.com
